$84.90
-1.04-1.21%
Last update: Oct 30, 4:00 PM
Agilon Health Inc
AGLNYSE
Agilon Health (AGL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Agilon Health (AGL) last issued guidance on August 5, 2026 for Q3 2026. The company guided revenue in the range of $1.45B - $1.48B for the period.
Compared to prior guidance, Agilon Health lowered its revenue forecast from a prior range of $5.78B - $5.86B.
Agilon Health has issued 27 guidance updates between November 3, 2022 and August 5, 2026. During this period, the company raised its outlook 8 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.14 | $0.95 | $-6.75 | $-4.00 |
| Actual | $1.04 | $1.80 | $-11.50 | $-6.75 |
| Surprise | +642.9% | +89.5% | -70.4% | -68.8% |
| Revenue | ||||
| Estimate | $1.45B | $1.38B | $1.46B | $1.43B |
| Actual | $1.49B | $1.42B | $1.57B | $1.44B |
| Surprise | +3.11% | +2.94% | +7.40% | +0.70% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.99 | $-3.70 | $1.78 | $3.84 |
| Revenue | ||||
| Consensus | $1.46B | $1.46B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.04 | $0.14 | 642.9 % |
| Q1 | May 6, 2026 | $1.80 | $0.95 | 89.5 % |
| Q4 | Feb 25, 2026 | $-11.50 | $-6.75 | -70.4 % |
| Q3 | Nov 4, 2025 | $-6.75 | $-4.00 | -68.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.49B | $1.45B | 3.11 % |
| Q1 | May 6, 2026 | $1.42B | $1.38B | 2.94 % |
| Q4 | Feb 25, 2026 | $1.57B | $1.46B | 7.40 % |
| Q3 | Nov 4, 2025 | $1.44B | $1.43B | 0.70 % |
